Distinguishing Molecular Features of Allergic Fungal Rhinosinusitis

Matthew A Tyler1, Caroline J Padro Dietz1,2, Chris B Russell3

  • 11 Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, Texas, USA.

Insights

Allergic fungal rhinosinusitis (AFRS) has distinct molecular features from chronic rhinosinusitis with nasal polyps (CRSwNP), including unique immune gene expression and altered salivary peptide levels, impacting fungal growth control.

Area of Science:

  • Immunology
  • Otolaryngology
  • Molecular Biology

Background:

  • Allergic fungal rhinosinusitis (AFRS) is a subtype of chronic rhinosinusitis with nasal polyps (CRSwNP).
  • The distinct pathophysiology of AFRS compared to CRSwNP remains debated.
  • Identifying unique molecular features of AFRS is crucial for understanding its pathogenesis.

Purpose of the Study:

  • To identify molecular characteristics that differentiate AFRS from CRSwNP.
  • To investigate the role of immune gene expression and salivary peptides in AFRS.

Main Methods:

  • Cross-sectional case-control study involving 86 patients (CRSwNP, AFRS, healthy controls).
  • Whole-genome microarray analysis of surgically treated patients.
  • Validation using quantitative polymerase chain reaction and immunohistochemistry.

Main Results:

  • AFRS demonstrated a strong association with adaptive T helper 2-associated immune gene expression.
  • Altered expression of histatins, salivary peptides with antifungal activity, was observed in AFRS.
  • Histatin expression negatively correlated with type 2 inflammatory mediators and was decreased in AFRS compared to CRSwNP.

Conclusions:

  • Clear molecular profiles distinguish AFRS from CRSwNP.
  • Altered histatin expression in AFRS may impair fungal growth control.
  • These molecular differences contribute to the distinct phenotypes of CRSwNP and AFRS.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
32.4K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
3
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.9K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
1.4K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
1